Given the significance of the PTEN/PI3K/AKT signaling axis in T-ALL cell survival [18], our results provide a molecular basis for the observed induction of apoptosis in ON108110 treated cells and a strong rationale for targeting CK2 and CDK4/6 in MCL and T-ALL. This evidence concerns the gene AKT1 and acute lymphoblastic leukemia.